这是一篇来自已证抗体库的有关人类 CA9的综述,是根据18篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合CA9 抗体。
CA9 同义词: CAIX; carbonic anhydrase 9; CA-IX; P54/58N; RCC-associated antigen G250; RCC-associated protein G250; carbonate dehydratase IX; carbonic anhydrase IX; carbonic dehydratase; membrane antigen MN; pMW1; renal cell carcinoma-associated antigen G250

安迪生物R&D
小鼠 单克隆(303123)
  • 免疫组化-冰冻切片; 人类; 1:100; 图 4c
安迪生物R&D CA9抗体(R&D Systems, FAB2188P)被用于被用于免疫组化-冰冻切片在人类样品上浓度为1:100 (图 4c). Science (2018) ncbi
山羊 多克隆
  • 免疫沉淀; 人类; 图 1h
安迪生物R&D CA9抗体(R&D systems, AF2188)被用于被用于免疫沉淀在人类样品上 (图 1h). Oncogene (2017) ncbi
小鼠 单克隆(303123)
  • 流式细胞仪; 人类; 图 2a
安迪生物R&D CA9抗体(R&D Systems, FAB2188A)被用于被用于流式细胞仪在人类样品上 (图 2a). Cancer Sci (2017) ncbi
山羊 多克隆
  • 其他; 人类; 100 ng/ml
安迪生物R&D CA9抗体(R&D, BAF2188)被用于被用于其他在人类样品上浓度为100 ng/ml. Oncotarget (2016) ncbi
小鼠 单克隆(303123)
  • 流式细胞仪; 人类; 图 st1
安迪生物R&D CA9抗体(R&D Systems, FAB2188P)被用于被用于流式细胞仪在人类样品上 (图 st1). Exp Cell Res (2016) ncbi
山羊 多克隆
  • 免疫组化-石蜡切片; 人类; 1:200
安迪生物R&D CA9抗体(R&D, AF2188)被用于被用于免疫组化-石蜡切片在人类样品上浓度为1:200. J Enzyme Inhib Med Chem (2014) ncbi
安迪生物R&D CA9抗体(R&D, DCA900)被用于. PLoS ONE (2012) ncbi
Novus Biologicals
兔 多克隆
  • 免疫印迹; 人类; 1:5000; 图 1f
Novus Biologicals CA9抗体(Novus, NB100-417)被用于被用于免疫印迹在人类样品上浓度为1:5000 (图 1f). EMBO Mol Med (2018) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图 13
Novus Biologicals CA9抗体(Novus Biologicals, NB100-417)被用于被用于免疫印迹在人类样品上 (图 13). PLoS ONE (2016) ncbi
兔 多克隆
  • 免疫组化-石蜡切片; 人类; 1:2000; 图 6
Novus Biologicals CA9抗体(Novus Biologicals, #NB100?\417)被用于被用于免疫组化-石蜡切片在人类样品上浓度为1:2000 (图 6). EMBO Mol Med (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图 4
Novus Biologicals CA9抗体(Novus Biologicals, NB100-417)被用于被用于免疫印迹在人类样品上浓度为1:1000 (图 4). J Cell Sci (2016) ncbi
兔 多克隆
  • 免疫细胞化学; common platanna; 1:500; 图 5c
  • 免疫印迹; common platanna; 1:500; 图 1e
  • 免疫细胞化学; 人类; 1:500; 图 5a
Novus Biologicals CA9抗体(Novus Biologicals, NB100-417)被用于被用于免疫细胞化学在common platanna样品上浓度为1:500 (图 5c), 被用于免疫印迹在common platanna样品上浓度为1:500 (图 1e) 和 被用于免疫细胞化学在人类样品上浓度为1:500 (图 5a). FEBS J (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图 s2
Novus Biologicals CA9抗体(Novus Biologicals, NB100-417)被用于被用于免疫印迹在人类样品上 (图 s2). Cell Cycle (2014) ncbi
艾博抗(上海)贸易有限公司
兔 多克隆
  • 免疫组化-石蜡切片; 人类; 1:1000; 表 3
艾博抗(上海)贸易有限公司 CA9抗体(Abcam, ab128883)被用于被用于免疫组化-石蜡切片在人类样品上浓度为1:1000 (表 3). Oncol Lett (2016) ncbi
兔 单克隆(EPR4151(2))
  • 免疫印迹; 人类; 图 5
艾博抗(上海)贸易有限公司 CA9抗体(Abcam, ab108351)被用于被用于免疫印迹在人类样品上 (图 5). J Biol Chem (2016) ncbi
赛默飞世尔
小鼠 单克隆(GT12)
  • 抑制或激活实验; 人类; 图 8
  • 免疫印迹; 人类; 1:250; 图 6
赛默飞世尔 CA9抗体(Fisher Scientific, MA5-16318)被用于被用于抑制或激活实验在人类样品上 (图 8) 和 被用于免疫印迹在人类样品上浓度为1:250 (图 6). FEBS J (2016) ncbi
赛信通(上海)生物试剂有限公司
兔 单克隆(D10C10)
  • 免疫印迹; 小鼠; 图 2d
赛信通(上海)生物试剂有限公司 CA9抗体(Cell Signaling, 5648)被用于被用于免疫印迹在小鼠样品上 (图 2d). Sci Signal (2017) ncbi
兔 单克隆(D47G3)
  • 免疫组化; 人类; 1:200
赛信通(上海)生物试剂有限公司 CA9抗体(Cell Signaling, D47G3)被用于被用于免疫组化在人类样品上浓度为1:200. Int J Clin Exp Pathol (2015) ncbi
文章列表
  1. Greenhough A, Bagley C, Heesom K, Gurevich D, Gay D, Bond M, et al. Cancer cell adaptation to hypoxia involves a HIF-GPRC5A-YAP axis. EMBO Mol Med. 2018;10: pubmed 出版商
  2. Young M, Mitchell T, Vieira Braga F, Tran M, Stewart B, Ferdinand J, et al. Single-cell transcriptomes from human kidneys reveal the cellular identity of renal tumors. Science. 2018;361:594-599 pubmed 出版商
  3. Swayampakula M, McDonald P, Vallejo M, Coyaud E, Chafe S, Westerback A, et al. The interactome of metabolic enzyme carbonic anhydrase IX reveals novel roles in tumor cell migration and invadopodia/MMP14-mediated invasion. Oncogene. 2017;36:6244-6261 pubmed 出版商
  4. CAROMILE L, Dortche K, Rahman M, Grant C, Stoddard C, Ferrer F, et al. PSMA redirects cell survival signaling from the MAPK to the PI3K-AKT pathways to promote the progression of prostate cancer. Sci Signal. 2017;10: pubmed 出版商
  5. Nasu K, Yamaguchi K, Takanashi T, Tamai K, Sato I, Ine S, et al. Crucial role of carbonic anhydrase IX in tumorigenicity of xenotransplanted adult T-cell leukemia-derived cells. Cancer Sci. 2017;108:435-443 pubmed 出版商
  6. Liu S, Tian Z, Zhang L, Hou S, Hu S, Wu J, et al. Combined cell surface carbonic anhydrase 9 and CD147 antigens enable high-efficiency capture of circulating tumor cells in clear cell renal cell carcinoma patients. Oncotarget. 2016;7:59877-59891 pubmed 出版商
  7. Frohwitter G, Buerger H, van Diest P, Korsching E, Kleinheinz J, Fillies T. Cytokeratin and protein expression patterns in squamous cell carcinoma of the oral cavity provide evidence for two distinct pathogenetic pathways. Oncol Lett. 2016;12:107-113 pubmed
  8. Ono M, Yamada K, Bensaddek D, Afzal V, Biddlestone J, Ortmann B, et al. Enhanced snoMEN Vectors Facilitate Establishment of GFP-HIF-1α Protein Replacement Human Cell Lines. PLoS ONE. 2016;11:e0154759 pubmed 出版商
  9. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed 出版商
  10. Black J, Zhang H, Kim J, Getz G, Whetstine J. Regulation of Transient Site-specific Copy Gain by MicroRNA. J Biol Chem. 2016;291:4862-71 pubmed 出版商
  11. Scholz A, Harter P, Cremer S, Yalcin B, Gurnik S, Yamaji M, et al. Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma. EMBO Mol Med. 2016;8:39-57 pubmed 出版商
  12. Ortmann B, Bensaddek D, Carvalhal S, Moser S, Mudie S, Griffis E, et al. CDK-dependent phosphorylation of PHD1 on serine 130 alters its substrate preference in cells. J Cell Sci. 2016;129:191-205 pubmed 出版商
  13. Klier M, Jamali S, Ames S, Schneider H, Becker H, Deitmer J. Catalytic activity of human carbonic anhydrase isoform IX is displayed both extra- and intracellularly. FEBS J. 2016;283:191-200 pubmed 出版商
  14. Müller W, Schröder H, Tolba E, Diehl Seifert B, Wang X. Mineralization of bone-related SaOS-2 cells under physiological hypoxic conditions. FEBS J. 2016;283:74-87 pubmed 出版商
  15. Kuroda N, Agatsuma Y, Tamura M, Martinek P, Hes O, Michal M. Sporadic renal hemangioblastoma with CA9, PAX2 and PAX8 expression: diagnostic pitfall in the differential diagnosis from clear cell renal cell carcinoma. Int J Clin Exp Pathol. 2015;8:2131-8 pubmed
  16. Mudie S, Bandarra D, Batie M, Biddlestone J, Moniz S, Ortmann B, et al. PITX1, a specificity determinant in the HIF-1α-mediated transcriptional response to hypoxia. Cell Cycle. 2014;13:3878-91 pubmed 出版商
  17. Pan J, Lau J, Mesak F, Hundal N, Pourghiasian M, Liu Z, et al. Synthesis and evaluation of 18F-labeled carbonic anhydrase IX inhibitors for imaging with positron emission tomography. J Enzyme Inhib Med Chem. 2014;29:249-55 pubmed 出版商
  18. Goodison S, Chang M, Dai Y, Urquidi V, Rosser C. A multi-analyte assay for the non-invasive detection of bladder cancer. PLoS ONE. 2012;7:e47469 pubmed 出版商